Navigation Links
Nektar Therapeutics Reports Third Quarter 2011 Financial Results
Date:11/2/2011

on partners are in various stages of clinical development and the risk of failure is high and can unexpectedly occur at any stage prior to regulatory approval for numerous reasons including safety and efficacy findings even after positive findings in preclinical and clinical studies; (ii) the timing of the commencement or end of clinical trials, the announcement of clinical trial results, and the commercial launch of our drug candidates may be delayed or unsuccessful due to regulatory delays, slower than anticipated patient enrollment, manufacturing challenges, changing standards of care,  evolving regulatory requirements, clinical trial design, clinical outcomes, competitive factors, or delay or failure in ultimately obtaining regulatory approval in one or more important markets; (iii) scientific discovery of new medical breakthroughs is an inherently uncertain process and the future success of the application of Nektar's technology platform to potential new drug candidates is therefore highly uncertain and unpredictable and one or more research and development programs could fail; (iv) Nektar's patent applications for its proprietary or partner product candidates may not issue, patents that have issued may not be enforceable, or additional intellectual property licenses from third parties may be required in the future; (v) the outcome of any future intellectual property or other litigation related to Nektar's proprietary product candidates or complex commercial agreements; and (vi) certain other important risks and uncertainties set forth in Nektar's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 5, 2011.  Actual results could differ materially from the forward-looking statements contained in this press release.  Nektar undertakes no obligation to update forward-looking statements, whether as a result of new information, future events or otherwise.Nektar Investor Inquiries:Jennifer Ruddock/Nektar Therapeuti
'/>"/>
SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
2. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
3. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
4. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
5. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
6. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
7. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
8. Nektar Therapeutics Reports Second Quarter 2009 Financial Results
9. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
10. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
11. Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Aug. 22, 2014  Medical Science Liaisons serve as ... in the healthcare sector. As the impact of technology ... changing how Medical Science Liaisons (MSLs) interact with physicians ... using the tablet to not only share important disease ... coordinate thought leader interactions across geographies and therapeutic areas. ...
(Date:8/22/2014)... 22, 2014 ... has announced the addition of the  "Global ... their offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... instrument for any modern science laboratory as ... materials. It can be broadly classified into ...
(Date:8/22/2014)... DUBLIN , August 22, 2014 /PRNewswire/ ... ) has announced the addition of the  ... to their offering.       (Logo: ... room with a sterile environment in a ... It is equipped with technically advanced equipment, ...
Breaking Medicine Technology:iPads Enhancing Medical Science Liaison Interactions with Thought Leaders, New Study Shows 2Global Laboratory Electronic Balance Market 2014-2018: Key Vendors are A&D Company, Mettler-Toledo, Sartorius and Thermo Fisher 2Global Operating Room Equipment Market 2014-2018: Key Vendors are Getinge, STERIS, Stykron and TRUMPF Medical Systems 2
... The U.S. Food and Drug Administration approved on June 13 ... with osteoarthritis. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... shape of a ball at the top of the ... the pelvis (acetabulum).  During total hip replacement surgery, worn ...
... SAN MARINO, Calif., June 14, 2011 Viral ... transition to a clinical-stage company. The Company,s two ... various Metabolic Disruption (MDT) compounds for drug-resistant cancers ... sponsor- or investigator-initiated Investigational New Drug (IND) pathways. ...
Cached Medicine Technology:FDA Approves First Ceramic-on-Metal Total Hip Replacement System 2Viral Genetics Updates HIV/AIDS and Drug Resistant Cancer Research Programs 2Viral Genetics Updates HIV/AIDS and Drug Resistant Cancer Research Programs 3Viral Genetics Updates HIV/AIDS and Drug Resistant Cancer Research Programs 4
(Date:8/22/2014)... The IT manager of Top10BestSEOHosting.com is a ... years. He has recently announced that GoDaddy ( http://www.top10bestseohosting.com/go/GoDaddy.com/ ... 2014. , GoDaddy is a popular supplier of cheap ... hosting solutions at affordable rates. It offers three Linux ... plans depend on the length of the contract. The ...
(Date:8/22/2014)... Recently, Skmen.com, an experienced supplier of fashionable ... dresses in its online store. Moreover, all these excellent ... 28% off. All the international clients can obtain these ... , The company’s professional online workers update its ... customers more the latest information about its new arrivals ...
(Date:8/22/2014)... Top 10 Best SEO Hosting (Top10BestSEOHosting.com) ... and highly recommended FatCow ( http://www.top10bestseohosting.com/go/FatCow.com/ ) and ... Top 10 Best SEO Hosting states, “It is ... supplier. Actually, these companies have outperformed their competitors ... support. People can get the best web hosting ...
(Date:8/22/2014)... (PRWEB) August 23, 2014 This ... (Instruments (Workstations, Liquid Handling Systems), Consumables (Tubes), Kits ... Users (Molecular Diagnostics) - Global Forecast to 2018" ... 2013 and is poised to grow at a ... reach $5,672.0 million by 2018. , Browse 98 ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Japantown Dental ... a new teeth whitening technique. Air polishing is a ... appointments. , Dark teeth can be caused by a ... external stains and internal stains. External stains include coffee, ... be caused by certain medications, such as tetracycline, and ...
Breaking Medicine News(10 mins):Health News:Cheap Bohemian Dresses Unveiled by Experienced Supplier Skmen.com 2Health News:FatCow Reviews Released by Top10BestSEOHosting.com 2Health News:Sample Preparation Market by Product and Application Worth $5,672 Million by 2018 - New Research Report by MarketsandMarkets 2Health News:Sample Preparation Market by Product and Application Worth $5,672 Million by 2018 - New Research Report by MarketsandMarkets 3Health News:Sample Preparation Market by Product and Application Worth $5,672 Million by 2018 - New Research Report by MarketsandMarkets 4Health News:Japantown Dental Introduces Air Polishing 2
... likely to die after coronary artery bypass grafting (CABG) ... ,Other studies examining the link between depression and ... either because of small sample size or short follow-up. ... Centers in Durham, North Carolina, assessed the outcomes of ...
... imaging techniques -- the so-called CT and PET scans -- ... study.// ,Italian researchers from the National Cancer Institute in ... (or positron emission tomography) scans in their study of more ... minimum of 26 cigarettes a day for 37 years. ...
... head and neck cancers that’s aimed at boosting the ... and neck cancers have suppressed immune systems, and these ... development of the cancerous tumors. Research also exists suggesting ... in treating various forms of cancer by boosting immune ...
... In one of the first studies of its kind, ... on health. The study, led by doctors at the ... impacts the left side of the brain and has ... in a work environment with healthy employees. During an ...
... than other people, scientists said on Friday. Researchers in Denmark ... who died between 1943 and 1993 and compared their rates ... suicide rate was lower for twins, regardless of their sex.// ... have suggested that twins are slightly more prone to mental ...
... patients less likely to have a heart attack, U.S. ... inhibitors (SSRIs), such as sertraline (Zoloft), make the blood ... ,The study, published in the American Heart Association ... //should check heart patients for depression and treat it ...
Cached Medicine News:
The ABL77 is always ready to use. No manual cassette preparation or calibration necessary prior to testing. Portable with battery. For both high and low volume testing....
... importance of electronic connectivity for ... understood. Transmission of patient results ... records, and billing. A sound ... connectivity is essential to ensure ...
348 is fully automated blood gas systems offering a cost-effective solution for critical care testing in settings with low to medium workloads....
248 is fully automated blood gas systems offering a cost-effective solution for critical care testing in settings with low to medium workloads....
Medicine Products: